24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Ask me anything Champion sponsor of the Annual Meeting Reported by Devorah Weinstock Speakers Caroline Halford, Chief Publishing Officer, PLOS Alan Moore, Digital Publishing Manager, Adis | Springer Healthcare Ltd Shawn Morton, Senior Editorial Director, Health Sciences, Wiley Niamh O’Connor, Chief Publishing Officer, PLOS This session with journal editors was packed with rich and relevant…
Scientific communication Champion sponsor of the Annual Meeting Reported by Olivia McKenna Speaker Lisa DeTora, Associate Professor of Writing Studies and Rhetoric and Director, STEM Writing, Hofstra University Lisa DeTora delivered a very interesting presentation on how to improve scientific communication in an open world by leveraging Aristotle’s rhetorical concepts of practical wisdom (phonese), applied…
“Open” research Champion sponsor of the Annual Meeting Reported by Sarah Sabir Speaker Niamh O’Connor, Chief Publishing Officer, PLOS Niamh O’Connor kicked off her keynote presentation by recalling the beginning of PLOS in 2000. The founders had received more than 34 000 signatures from scientists across 180 countries in an open letter calling for medical science…
We are watching, with you, the events that are unfolding in the USA. At Oxford PharmaGenesis, we value diversity of culture and of opinion in our aspiration to uphold an environment in which employees can be themselves and express their views. This ideal is woven into our company’s philosophy, which speaks to maintaining a workplace that…
We were excited to participate in the first ever ASCO virtual annual meeting last week. Although we missed the in-person interactions, we did not miss the travelling, and it was great to hear about all the exciting developments in cancer research from the comfort of our own homes!
HEOR and RWE in the COVID-19 pandemic: highlights from the first virtual ISPOR meeting In May 2020, members of the Oxford PharmaGenesis Value Demonstration Practice joined more than 1300 health economic and outcomes research (HEOR) and market access professionals from 54 countries for the first ever fully virtual ISPOR meeting, participating in a broad range…
